FVR Should Be Happy; DOST Reveals VCO Study Results versus Coronavirus 

Twitter: @edd1819, Instagram: @bluestar0910, Facebook: SDN — Science, Digital & Current Affairs

“The Effects of Virgin Coconut Oil among Suspect and Probable Cases of Covid-19” is a study the Department of Science and Technoloy (DOST) conducted as part of the Philippine government’s ongoing battle against the 2019 coronavirus disease (Covid-19). DOST Secretary Fortunato T. de la Peña leads today’s unveiling of the results through a virtual media briefing.

DOST unveils results of study on VCO.
Science Secretary Fortunato T. de la Peña. (SDN — Science & Digital News screen grab from DOST virtual media coverage)

By EDD K. USMAN

(SDN) December 3, 2020 — ERSTWHILE President Fidel V. Ramos would be happy with this!

The former Philippines Chief Executive has been a prominent user of virgin coconut oil (VCO), taking a spoonful of the sticky substance every meal — that’s breakfast, lunch, and dinner.

Ramos is also known to be mixing it on his cup of coffee, according to former peace adviser secretary Jesus Dureza.

In one trip to Davao City, on board a Philippine Airlines (PAL) jumbo jet, Ramos told this journalist his penchant for taking the VCO in his meals. He was then flying to Mindanao in September 2007 to join the 11th anniversary celebration of the 1996 Final Peace Agreement (FPA).

———

“You know, I am taking a spoonful of Virgin Coconut Oil every meal,” he revealed, unsolicited. We were standing on the plane’s aisle, 33,000 feet high, his arms on my shoulders.

———

Mainly because he consumes VCO, he would surely welcome the encouraging results of the study on “The Effects of Virgin Coconut Oil among Suspect and Probable Cases of Covid-19” conducted by the Department of Science and Technoloy (DOST).

Now, before anyone gets it wrong, the former President has no coronavirus infection.

But long before the coronavirus pandemic, Ramos is a VCO believer of its potentials for a healthy life. There are many like him in the country.

On Thursday, December 3, de la Peña led the unveiling of VCO study implemented for 28 days in Sta. Rosa, Laguna, for 57 “suspect or probable” cases of SARS-CoV-2 infection, the pathogen that causes Covid-19. In particular, it was done at the Sta. Rosa Community Hospital Isolation Unit and Sta. Rosa Community Isolation Unit in collaboration with the DOST CALABARZON (Region IV-A) under Regional Director Alexander R. Madrigal.

Study participants showed coronavirus signs and symptoms. Asymptomatic were not included.

The Food and Nutrition Research Institute (DOST-FNRI) conducted the study as the government steps up efforts aimed at containing the pandemic.

As to why the VCO, the DOST explained it.

“Virgin coconut oil or VCO has been reported in several scientific studies to have anti-viral activities against several viruses, like in the research of Dr. (Fabian) Dayrit of the Ateneo de Manila (University) among HIV patients,” the DOST chief pointed out.

De la Peña added the said studies presented “an affordable and readily available supplement to help minimize the symptoms caused by these viruses, thereby preventing severity of illnesses.”

In fact, the DOST through the FNRI as enunciated by DOST Assistant Scientist Dr. Imelda Angeles-Agdeppa will recommend VCO as “adjunct food supplement for suspect or probable” Covid-19 case. She described the results of the study as “significant.” In saying “adjunct”, she meant VCO added to treatment of those are suspect or probable coronavirus cases.

DOST reveals VCO study results vs. coronavirus
DOST Assistant Scientist Dr. Imelda Angeles-Agdeppa of FNRI. (Screen grab by SDN — Science & Digital News from DOST virtual media briefing on VCO study versus coronavirus)

Why so?

In his introductory remarks, de la Peña said the study respondents were divided into the Intervention or VCO Group and the Contolled Group.

The VCO Group was given VCO mixed in meals with the recipes FNRI prepared. For the Controlled Group they got the said standard meals but without VCO. It was conducted in 28 days.

Here’s de la Peña again for the results:

“From the first to the third day, the VCO Group received 0.6 milliliters of VCO per kilogram of their bodyweight during breakfast.
 
“From Day 4 to Day 28, the VCO Group received 1.2 milliliters of VCO per kilogram of their bodyweight during breakfast and lunch.
 
“For participants in the VCO group with reported intolerance, computed VCO per kilogram of their bodyweight was given during breakfast, lunch and dinner
 
“With regards to monitoring, signs and symptoms, like cough, colds, body aches, headache, loss of taste and fever were checked daily.
 
“The C-Reactive Protein or CRP was monitored at Day 1, 14, and 28.
 
“C-Reactive Protein or CRP is a quantitative marker used to monitor inflammation or infection. 
 
“A CRP equal or less than 5 milligrams per liter signifies recovery from inflammation or infection.
 
“Results of the VCO study showed that 5 of the 29 patients in the VCO Group manifested diminishing signs and symptoms as early as the second day, while only 1 from the Control Group showed similar improvement.
 
“The VCO Group showed no COVID-19 related symptoms at Day 18, while symptoms persisted in some patients of the Control Group until Day 23.
 
“Mean C-Reactive Protein or CRP levels in the VCO Group normalized to 5 milligrams per liter or less as early as Day 14.
 
“While reduction to normal CRP levels in the Control Group was also evident from Day 1 to 14, it remained at the borderline of 5 milligrams per liter from Day 14 until end of intervention.
 
“The VCO Group has recovered from infection or inflammation approximately 14 days after being subjected to the intervention.
 
“In conclusion, symptoms in the VCO Group significantly declined at Day 2 and no symptoms were observed at Day 18.
 
“Compare this to the Control Group that showed diminishing symptoms at Day 3 and no symptoms only at Day 23.
 
“This is evidently supported by the normal CRP levels in the VCO Group.
On the other hand, the DOST emphasized the study still needs further research, at the same time the results do not mean VCO has curative or therapeutic effect on Covid-19, nor a treatment.
To be declared for therapeutic effect, lots of clinical studies are needed, said Dayrit, president of the National Academy of Science and Technology (NAST) of the DOST.
And before everyone runs to the supermarkets or groceries or drugstores to grab a bottle of VCO, the Philippine Coconut Authority (PCA) through Board Member and former Armed Forces of the Philippines (AFP) chief of staff General Benjamin Madrigal said nine VCO producers applied to include their products in the DOST study. Only six qualified, he revealed.
However, the PCA was not inclined to reveal the names of the six VCO brands in the research, neither the three brands rejected.
Board Member Madrigal’s advice: Choose the VCO brand with seal of approval from the Food and Drug Administration (FDA).
He added the PCA, which also helped fund the DOST study, will ask VCO producers to create standards for their products. (✓)

Don't be shy, comments are welcome! Thank you.

This site uses Akismet to reduce spam. Learn how your comment data is processed.

Discover more from SDN -- Science & Digital News

Subscribe now to keep reading and get access to the full archive.

Continue reading